XAXin Ai

Xin Ai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xin Ai has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Bingxue Bai

    Department of Dermatology The Second Affiliated Hospital of Harbin Medical University Harbin China

    2 shared publications
  • Chen Zhao

    Department of Ultrasound Medicine The Second Affiliated Hospital of Harbin Medical University Harbin China

    2 shared publications
  • Jia Chen

    Department of Dermatology The First Affiliated Hospital of Heilongjiang University of Chinese Medicine Harbin China

    2 shared publications
  • Xiaoping Leng

    Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    2 shared publications
  • Zhuo Wang

    Department of Ultrasound Medicine The Second Affiliated Hospital of Harbin Medical University Harbin China

    2 shared publications
  • Feihang Dai

    Department of Ultrasound Second Affiliated Hospital of Harbin Medical University Harbin China

    1 shared publication

Latest Publications

  • Assessing Treatment Efficacy in Alopecia Areata: A Combined High‐Frequency Ultrasound and Superb Microvascular Imaging Study

    by Meng Yang, Chen Zhao, Jia Chen, Xin Ai, Shouqiang Li, Zhuo Wang, Zhinuo Li, Zhirou Di, Bingxue Bai, Xiaoping Leng

    Objectives: The therapeutic goals for alopecia areata (AA) are to suppress local immune inflammation, restore hair follicle structure, and improve surrounding blood perfusion. However, current efficacy evaluations largely rely on subjective clinical observation and lack objective quantitative methods. High‐frequency ultrasound (HFUS) can clearly display the location and morphology of hair follicles. Combined with microvascular assessment techniques, it enables quantitative detection of low‐velocity blood flow and related parameters, providing an objective basis for evaluating AA treatment efficacy. Methods: Forty‐five patients with AA who received intralesional therapy underwent HFUS (measuring epidermal/dermal thickness and hair follicle length/width) and ultrasound microvascular assessment, including spectral Doppler measurement of peak systolic velocity (PSV), resistance index (RI), and power Doppler measurement of vascular index (VI) before and after treatment. Patients were divided into a responder group ( n = 37) and an ineffective group ( n = 8) based on the reduction rate of the SALT score. The Mann–Whitney U test and Wilcoxon signed‐rank test were used for comparisons between groups and within the responder group (pre‐treatment versus post‐treatment), respectively. Results: Baseline characteristics showed no statistically significant differences (all p > .05). Patients in the ineffective group exhibited poorer hair follicle morphology (shorter length, greater width, and lower length‐to‐width ratio), but higher PSV and VI compared to the responder group ( p < .05). In the responder group, treatment significantly improved hair follicle morphology, increased PSV and VI ( p < .05), but RI showed no change. Conclusions: (1) HFUS technology can observe changes in AA hair follicle structure during the diagnosis and treatment process, evaluating the effectiveness of treatment regimens in improving AA disease progression. (2) SMI combined with Doppler flow parameters can monitor changes in the perifollicular microcirculation in AA, reflecting the improvement of microcirculation during the diagnosis and treatment of AA. (3) The synergistic application of HFUS and SMI technologies can provide an objective imaging basis for the clinical evaluation of AA treatment efficacy, demonstrating promising clinical application prospects.


  • Quantitative Evaluation of Treatment Efficacy in Papulopustular Rosacea Using High‐Frequency Ultrasound Combined With Ultra‐Micro Angiography Technology

    by Xin Ai, Bingxue Bai, Chen Zhao, Meng Yang, Feihang Dai, Zhuo Wang, Shouqiang Li, Wenjun Xu, Jinhong Liu, Xiaoping Leng, et al.

    Objectives: This study aims to apply high‐frequency ultrasound (HFUS) in conjunction with ultra‐micro angiography (UMA) technology to observe the ultrasound characteristics of facial lesions in patients with papulopustular rosacea (PPR). It will also quantitatively evaluate the changes before and after treatment, thereby assessing the feasibility and application value of this combined technique in evaluating the treatment efficacy for PPR. Methods: We conducted a prospective study involving 63 patients with PPR who visited the dermatology department between May 2024 and March 2025. Two attending dermatologists independently evaluated the most severe lesions on each patient's cheeks (marked area) and performed follow‐up evaluations at the end of the fourth week of treatment, as well as calculated the therapeutic efficacy index. We utilized HFUS, equipped with a 33 Hz linear array probe, in conjunction with UMA technology to conduct ultrasound scans of the marked areas of patients at baseline and at the end of the fourth week of treatment. This allowed us to obtain ultrasound characteristics and perform statistical analyses. Results: The dermatologists classified the PPR patients based on the therapeutic efficacy index into cured (6 cases), significantly improved (23 cases), improved (29 cases), and ineffective (5 cases). By the end of the fourth week of treatment, significant changes were observed in non‐quantitative features, including epidermal morphology, the subepidermal low‐echogenic band, dermal echogenicity, sebaceous gland echogenicity, and the echoes of inflammatory papules, compared to baseline ( p < .01). Simultaneously, quantitative parameters, including thickness ratio, maximum diameter of hair follicles, maximum diameter of facial skin microvessels, peak systolic velocity, time average maximum velocity, and color pixel percentage (CPP), all significantly decreased ( p < .01). Spearman correlation analysis indicated a strong correlation between quantitative parameters, such as CPP and the relative change ratio of color pixel percentage, and the therapeutic efficacy index at the end of the fourth week of treatment (0.70 ≤ | r | < 0.90, p < .01). Conclusions: HFUS combined with UMA technology can be effectively used for the quantitative evaluation of treatment efficacy in PPR.